Biocatalysts for the preparation of hydroxy substituted carbamates

Patent metadata

Field	Value
Publication number	US-11713451-B2
Application number	US-202017084405-A
Country	US
Kind code	B2
Filing date	Oct 29, 2020
Priority date	Nov 18, 2011
Publication date	Aug 1, 2023
Grant date	Aug 1, 2023

Abstract

The present disclosure relates to engineered ketoreductase polypeptides for the preparation of hydroxyl substituted carbamate compounds, and polynucleotides, vectors, host cells, and methods of making and using the ketoreductase polypeptides.

First claim

What is claimed is:

1. An engineered polynucleotide encoding an engineered ketoreductase polypeptide capable of converting substrate compound (2), tert-butyl(1-oxo-1-phenylhex-5-yn-2-yl)carbamate, to product compound (1), tert-butyl(1-hydroxy-1-phenylhex-5-yn-2-yl)carbamate,

wherein the ketoreductase polypeptide comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO:4 and comprises a substitution X206F/L, further comprising one or more residue differences as compared to SEQ ID NO:4 selected from: X7S; X17M; X17Q; X17R; X23V; X27L; X29G; X40R; X60I; X64V; X71P; X87L; X94A; X94P; X94S; X95M; X96L; X96Y; X105G; X113I; X122A; X127R; X131S; X144V; X145L; X147I; X147L; X147Q; X150Y; X152G; X153G; X157C; X173L; X195A; X195G; X196M; X198S; X199H; X208R; X216R; X221S; X243S; X245I; X249F; X249G; and X249Y.

2. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 1 , wherein the amino acid sequence of said ketoreductase polypeptide comprises the substitution X206F/L and one or more residue differences as compared to SEQ ID NO:4 selected from: X7S; X17M; X17Q; X17R; X23V; X27L; X29G; X40R; X60I; X64V; X71P; X87L; X94A; X94P; X94S; X95M; X105G; X113I; X122A; X127R; X131S; X144V; X145L; X147I; X147L; X147Q; X150Y; X152G; X153G; X157C; X173L; X196M; X198S; X208R; X216R; X221S; X243S; X245I; X249F; X249G; and X249Y.

3. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 1 , wherein the amino acid sequence of said ketoreductase polypeptide comprises X206F/L, and at least one or more residue differences as compared to SEQ ID NO:4 selected from: X17Q/R/M; X40R; X64V; X94P; X96L/Y; X144V; X147Q/I/L; X157C; X195A/G; X196M; and X199H.

4. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 1 , wherein the ketoreductase polypeptide is capable of converting the substrate compound (2) to the product compound (1) with at least 10 fold the activity of the reference polypeptide of SEQ ID NO:4, wherein the amino acid sequence comprises the substitution X206F/L, and one or more residue differences as compared to SEQ ID NO:4 selected from: X40R; X60I; X71P; X94P; X94A; X95M; X96L; X96Y; X127R; X144V; X145I; X150Y; X152G; X153G; X157C; X195A; X195G; X196M; X198S; X199H; X216R, X245I, X245F; X249Y; and X249F.

5. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 1 , wherein the ketoreductase polypeptide has increased thermal stability as compared to the reference polypeptide of SEQ ID NO:4 or 32, wherein the amino acid sequence comprises the substitution X206F/L, and one or more residue differences as compared to SEQ ID NO:4 selected from: X17Q; X17R; X17W; X40R; X64V; X71P; X87L; X94S; X94P; X147Q; X147I; X147L; X157C, X198S; X249Y; and X249F.

6. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 1 , wherein the ketoreductase polypeptide is capable of forming product syn-tert-butyl(1-hydroxy-1-phenylhex-5-yn-2-yl)carbamate compounds (1a) and (1c)

in diastereomeric excess of anti-tert-butyl(1-hydroxy-1-phenylhex-5-yn-2-yl)carbamate compounds (1b) and (1d).

7. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 6 , wherein the amino acid sequence of the ketoreductase polypeptide further comprises or more residue differences as compared to SEQ ID NO:4 selected from: X17Q; X64V; X71P; X87L; X96L/Y; X147I; X157C; X195A/G; X196M; X199H; and X249F.

8. The engineered polynucleotide encoding an engineered ketoreductase polypeptide of claim 7 , wherein said ketoreductase polypeptide is capable of forming product compounds (1a) and (1c) in a diastereomeric ratio of at least 50 over compounds (1b) and (1d).

9. An expression vector comprising the polynucleotide of claim 1 .

10. An expression vector comprising the polynucleotide of claim 8 .

11. The expression vector of claim 9 , comprising at least one control sequence.

12. The expression vector of claim 11 , in which the control sequence is a promoter.

13. A host cell comprising the polynucleotide of claim 1 .

14. A host cell comprising the expression vector of claim 9 .

15. The host cell of claim 13 , wherein said host cell is E. coli.

16. The host cell of claim 14 , wherein said host cell is E. coli.

17. A method of preparing an engineered polypeptide comprising culturing the host cell of claim 13 , under conditions suitable for expression of the polypeptide, optionally further comprising isolating the engineered polypeptide.

18. A method of preparing an engineered polypeptide comprising culturing the host cell of claim 14 , under conditions suitable for expression of the polypeptide, optionally further comprising isolating the engineered polypeptide.

19. A method of preparing an engineered polypeptide comprising culturing the host cell of claim 15 , under conditions suitable for expression of the polypeptide, optionally further comprising isolating the engineered polypeptide.

20. A method of preparing an engineered polypeptide comprising culturing the host cell of claim 16 , under conditions suitable for expression of the polypeptide, optionally further comprising isolating the engineered polypeptide.

Assignees

• Codexis Inc

Inventors

• Cabirol Fabien Louis
• Chen Haibin
• Gohel Anupam
• Collier Steven J
• Smith Derek J
• Kosjek Birgit
• Janey Jacob

Classifications

• C12N9/0006 Primary

  acting on CH-OH groups as donors (1.1) · CPC title

• C12P13/00

  Preparation of nitrogen-containing organic compounds · CPC title

• C12P13/001

  Amines; Imines · CPC title

• C12P13/02

  Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

• C12P41/002

  by oxidation/reduction reactions · CPC title